The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. NeuroPace Inc shares valued at $52,278 were sold by Morrell Martha on Feb 05 ’24. At $15.17 per share, Morrell Martha sold 3,446 shares. The insider’s holdings dropped to 77,762 shares worth approximately $1.13 million following the completion of this transaction.
Also, Morrell Martha sold 14,143 shares, netting a total of over 213,122 in proceeds. Following the sale of shares at $15.07 each, the insider now holds 81,208 shares.
Before that, Morrell Martha had sold 663 shares from its account. In a trade valued at $9,971, the Chief Medical Officer traded NeuroPace Inc shares for $15.04 each. Upon closing the transaction, the insider’s holdings decreased to 663 shares, worth approximately $1.38 million.
As published in a research note from Wells Fargo on March 14, 2024, NeuroPace Inc [NPCE] has been rated up from an Equal weight to an Overweight and the price target has been revised to $20 from $16. Analysts at Leerink Partners started covering the stock with ‘”an Outperform”‘ outlook in a report released in late January. As of November 10, 2023, Cantor Fitzgerald has initiated its “an Overweight” rating for NPCE. Earlier on August 24, 2023, Morgan Stanley upgraded its rating. Their new recommendation was “an Equal-weight” for NPCE stock which previously was a “an Underweight”.
Analyzing NPCE Stock Performance
During the last five days, there has been a surge of approximately 14.21%. Over the course of the year, NeuroPace Inc shares have jumped approximately 40.69%. Shares of the company reached a 52-week high of $18.15 on 02/20/24 and a 52-week low of $9.50 on 01/03/24. A 50-day SMA is recorded $14.75, while a 200-day SMA reached $9.42. Nevertheless, trading volume fell to 0.52 million shares from 50200.0 shares the previous day.
Support And Resistance Levels for NeuroPace Inc (NPCE)
According to the 24-hour chart, there is a support level at 14.30, which, if violated, would cause prices to drop to 14.10. In the upper region, resistance lies at 14.80. The next price resistance is at 15.10. RSI (Relative Strength Index) is 53.49 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.98, which suggests the price will decrease in the coming days. Percent R is at 34.55%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
Is NeuroPace Inc subject to short interest?
Stocks of NeuroPace Inc saw a sharp steep in short interest on Mar 15, 2024 dropping by 31790.0 shares to 30930.0. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 62720.0 shares. A decline of -102.78% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 0.28 of the overall float, the days-to-cover ratio (short ratio) decline to 0.28.
